Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Petty

Psychiatry Loganville, GA Medical Doctor

NPI 1730334079 CMS profile 214788

2430 Tucker Dr, Bldg A, Loganville, GA 30052

Open in the dashboard

General payments

$2,850,710

3,105 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Richard Petty of Loganville, GA is reported in the CMS Open Payments database as having received $2,850,710 across 3,105 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $765,088 795
2024 General $642,055 714
2023 General $392,709 432
2022 General $331,996 366
2021 General $193,530 184
2020 General $188,991 197
2019 General $336,341 417

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Petty
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Richard Petty were reported at $765,088. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Richard Petty Psychiatry median Middle half National median
2019 $336,341 $184 $59–$605 $163
2020 $188,991 $119 $36–$372 $114
2021 $193,530 $143 $43–$576 $132
2022 $331,996 $153 $50–$590 $149
2023 $392,709 $170 $56–$651 $160
2024 $642,055 $179 $57–$673 $164
2025 $765,088 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. AbbVie, Inc. $686,773 663 payments
  2. ITI, Inc. $520,459 519 payments
  3. Vanda Pharmaceuticals Inc. $500,496 595 payments
  4. Axsome Therapeutics, Inc. $470,504 555 payments
  5. Allergan Inc. $282,642 311 payments
  6. Alkermes, Inc. $177,975 183 payments
  7. E.R. Squibb & Sons, L.L.C. $156,611 171 payments
  8. Sunovion Pharmaceuticals Inc. $28,432 52 payments
  9. Takeda Pharmaceuticals U.S.A., Inc. $23,788 43 payments
  10. Janssen Pharmaceuticals, Inc $3,007 12 payments
  11. Other $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,027,320 629 payments
  2. Travel and Lodging $331,164 1,485 payments
  3. Consulting Fee $260,675 80 payments
  4. Honoraria $181,554 104 payments
  5. Food and Beverage $49,929 805 payments
  6. Education $69 2 payments
Products named General payments · program years 2019–2025
  1. VRAYLAR Neuroscience $567,022 541 payments
  2. FANAPT $500,496 595 payments
  3. Auvelity $470,504 555 payments
  4. CAPLYTA $404,246 406 payments
  5. VRAYLAR Neuroscience $401,718 432 payments
  6. ARISTADA INITIO $177,975 183 payments
  7. ARISTADA Cns $177,975 183 payments
  8. ARISTADA Cns $177,975 183 payments
  9. ARISTADA Cns $177,975 183 payments
  10. ARISTADA Cns $177,975 183 payments
  11. Other $324,817 382 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

3,105 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Georgia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record